logo

Almost Family With A Stellar Quarter
By: TraderMark   Friday, November 07, 2008 10:37 AM
Symbols: AFAM, AMED, VWPT

So we'll see how that goes.

Always a worry in this sector is how Medicare and Medicaid reimbursement rules will change but recent rulings seem to be favorable
  • ,,,,the new rules expanded the number of billable diagnoses from 80 to 153 and ended the practice of increasing reimbursements by a lump sum once 10 visits are made for a particular treatment. Now, therapies involving between 6 and 20 visits have suddenly become more profitable for these firms.
Almost Family is no secret among the blogging community - in the past few months alone I see on Seeking Alpha
  1. Jun 18: Almost Family - Aging Demographics Will Drive Long Term Growth
  2. Jul 13: Almost Family - A Growing Company That will Benefit from Aging Baby Boomers
  3. Aug 7: Almost Family Trading Under the Radar
  4. Aug 12: Almost Family's a Buy, with Strong Revenues and Earnings Growth
  5. Aug 13: Almost Family - A Leading All Star in a Market That Isn't Going Anywhere Fast
So instead of recreating the wheel, I will encourage anyone interested in this name to read through the multiple postings above for a better flavor of the company. Now, I always like to hear the contrary viewpoint so I was hoping for a story such as "Aug 20: Almost Family - the Overvalued Beast I'm Shorting to Zero!" since thinking through the cons is always as important as the pros.

The chart? Excellent of late; in fact I'd be hard pressed to find a better one out there.

As I've been stating one area I think should do "relatively" well in the recession is healthcare - the elasticity of demand is a bit different - much of healthcare is a "need" not a "want". Remember (as we approach the labor report) that Walmart, federal government, and healthcare our the United States 3 growth industries.

But unlike the market which bid AFAM up on it's earnings I'd like to hear more about this shelf offering. A $40M filing (10% dilution) would be far different than say a $120M filing (30% dilution) - so this is going to create an overhang in my eyes until more data is presented. The full $150M capacity in the shelf would be nearly 40% dilution! But aside from that, we appear to have another solid niche story and one we want to have on our radar.

<< Previous Page12  

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Advertisement

Related Press Releases
Popular Articles
Advertisement
Recent Articles by TraderMark
Advertisement




Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia